Intravenous Access Devices Market

Intravenous Access Devices Market (Intravenous Needles, Intravenous Catheters and Intravenous Infusion Pumps) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

The rise inincidences of diseases along with the increasing number of diagnostic and treatment procedures are fuelling the demand for access devices such as intravenous access (IV) devices, arterial access devices and inter-muscular access devices. This is due to the fact that these access devices will enable the administration of various drugs such as analgesics, chemotherapy for its treatment, blood extraction for the diagnosis and delivery of nutrition.Among these access devices, intravenous access devices play a major role for the aforementioned purposes. Various IV access devices are available in the market such as IV needles, IV infusion pumps and IV catheters.The overall market is expected to grow at a CAGR of 7.8% from 2013 to 2019 to reach an estimated value of USD 46.4billion in 2019. This growth is attributed to rise in number of various surgeries in different regions of the globe. Similarly, rise in geriatric population worldwide will also support the growth of the market since they are more prone to various diseases due to decreased immunity in this age group. In addition, launch of technologically advanced products by various companies will also propel the growth of this market. For instance, Becton, Dickinson and Company launched world’s smallest pen intravenous needle which pierces the skin without causing much pain to the patients. Likewise, Smiths Medical launched Medfusion 4000 syringe infusion pump which is more precise in terms of drug volume administration over old version of syringe infusion pumps.
 
The market for intravenous catheters accounted for the largest market in terms of revenue among all IV access devices market in 2012 and is expected to grow at the highest CAGR in the future. This is attributed to its wide application areas andalso its utilization with other access devices such as infusion pumps and needles. Similarly, reasonable price over infusion pumps will also support its growth. In addition, catheters presence in the market is from long timethat has accounted for its popularity among the physicians.
 
The North American region accounted for the largest share by revenue for intravenous access devices in the year 2012 owing to large number of patient pool and geriatric population. However, Asia-Pacific is expected to show the highest growth rate of 9.4% from 2013 to 2019. This is attributed to rise in geriatric population, target diseases, increase in healthcare expenditure and improving healthcare infrastructure in the Asia-Pacific region.It is estimated that around 456,303 million people will be aged above 65 years by 2025 in Asia-Pacific. In addition, rise in disposable incomes due to economic development will also propel the growth of the market in the region since it will increase the purchasing power of individuals for various medical services such as surgeries.
 
The major players of the market include Hospira, Inc., Becton, Dickinson and Company, CareFusion Corporation, Baxter International, B. Braun Melsungen AG and Smiths Medical. Hospira, Inc., Becton, Dickinson and Company, CareFusion Corporation and Baxter International accounted for more than 50% of the total market till 2012. This is due to various business strategies adopted by them to have strong presence in the market such as entering in long term contracts with hospitals and diagnostic labs. Similarly, these companies are investing heavily for the development and launch of advanced version of devices, for instance, Medfusion 4000 syringe infusion pump is an advanced version of Medfusion 3500 syringe infusion pump that led to an increased demand for newer version.
     
    Chapter 1 Introduction
    1.1 Report Description
    1.2 Market Segmentation
    1.3 Research Methodology
     
    Chapter 2 Executive Summary
     
    Chapter 3 Market Overview
    3.1 Introduction
    3.2 Market Drivers
          3.2.1 Rise in incidences of target diseases such as cancer and viral infections
          3.2.2 Aging of the global population
                  3.2.2.1 Global Rate of Aging Population
          3.2.3 Increase in the development of vaccines
                  3.2.3.1 Pipeline Vaccines and Research Phase
          3.2.4 Technological advancements in product design
          3.2.5 Impact Analysis of Market Drivers
    3.3 Market Restraints
          3.3.1 Lack of regulatory approval for intravenous insulin infusion pumps in key markets such as the U.S.
          3.3.2 Risk associated with use of needles
          3.3.3 Impact Analysis of Market Restraints
    3.4 Market Opportunities
          3.4.1 Large target patient pool and rise in disposable income in emerging economies
    3.5 Porters Five Force Analysis for the Global Intravenous Access Devices Market
          3.5.1 Bargaining Power of Suppliers
          3.5.2 Bargaining Power of Buyers
          3.5.3 Threat of Substitutes
          3.5.4 Threat of New Entrants
          3.5.5 Competitive Rivalry
    3.6 Market Attractiveness Analysis
          3.6.1 Market Attractiveness Analysis: Global Intravenous Access Devices Market, by Geography 

    Chapter 4 Global Intravenous Access Devices Market, by Product Type
    4.1 Overview
          4.1.1 Global Intravenous Access Devices Market Revenue, by Product Type, 2011-2019 (USD Billion)
          4.1.2 Comparative Analysis: Global Intravenous Access Devices Market, by Product Type, 2012 & 2019 (Value %)
    4.2 Intravenous Needles
          4.2.1 Global Intravenous Needles Market Revenue, 2011 - 2019 (USD Billion)
    4.3 Intravenous Catheters
          4.3.1 Global Intravenous CatheterMarket Revenue, by Type, 2011 - 2019 (USD Billion)
          4.3.2 Midline Peripheral Catheters
                  4.3.2.1 Global Midline Peripheral Catheter Market Revenue, 2011 - 2019 (USD Billion)
          4.3.3 Central Catheters
                  4.3.3.1 Global Central CathetersMarket Revenue, by Type, 2011 - 2019 (USD Billion)
                  4.3.3.2 Peripherally Inserted Central Catheters (PICC)
                             4.3.3.2.1 Global Peripherally Inserted Central Catheter Market Revenue, 2011 - 2019 (USD Billion)
                 4.3.3.3 Centrally Inserted Central Catheters
                             4.3.3.3.1 Global Centrally Inserted Central Catheter Market Revenue, 2011 - 2019 (USD Billion)
    4.4 Intravenous Infusion Pumps
          4.4.1 Global Intravenous Infusion PumpsMarket Revenue, by Type, 2011 - 2019 (USD Billion)
          4.4.2 Insulin infusion Pumps
                  4.4.2.1 Global Intravenous Insulin infusion Pumps Market Revenue, 2011 - 2019 (USD Billion)
          4.4.3 Parenteral Feeding Infusion Pumps
                  4.4.3.1 Global Parenteral Feeding Infusion Pumps Market Revenue, 2011 - 2019 (USD Billion)
          4.4.4 Patient Controlled Analgesia (PCA) Infusion Pumps
                   4.4.4.1 Global Patient Controlled Analgesia (PCA) Infusion Pumps Market Revenue, 2011 - 2019 (USD Billion)
          4.4.5 Syringe Infusion Pumps
                  4.4.5.1 Global Syringe Infusion Pumps Market Revenue, 2011 - 2019 (USD Billion)
     
    Chapter 5 Global Intravenous Access Devices Market, by Geography
    5.1 Overview
          5.1.1 Global Intravenous Access Devices Market Revenue, by Geography, 2011 - 2019 (USD Billion)
          5.1.2 Comparative Analysis: Global Intravenous Access Devices Market, by Geography, 2012 & 2019 (Value %)
    5.2 North America
          5.2.1 North America Intravenous Access Devices Market Revenue, 2011 - 2019 (USD Billion)
    5.3 Europe
          5.3.1 Europe Geriatric Population Statistics (Million), 1991 - 2011
          5.3.2 Europe Intravenous Access Devices Market Revenue, 2011 - 2019 (USD Billion)
    5.4 Asia-Pacific
          5.4.1 Asia-Pacific Intravenous Access Devices Market Revenue, 2011 - 2019 (USD Billion)
    5.5 Rest of the World (RoW)
          5.5.1 Rest of the World (RoW) Intravenous Access Devices Market Revenue, 2011 - 2019 (USD Billion)
     
    Chapter 6 Competitive Landscape
    6.1 Market Share by Key Players, 2012 (%)
     
    Chapter 7 Recommendations
    7.1 Market Strategies for Success
          7.1.1 Entrance into long term contract with medical services providers
          7.1.2 Product innovations
          7.1.3 Broadening of distribution network
          7.1.4 Mergers and acquisitions
          7.1.5 Investing in emerging markets
     
    Chapter 8 Company Profiles
    8.1 Baxter International
          8.1.1 Company Overview
          8.1.2 Financial Overview
          8.1.3 Product Portfolio
          8.1.4 Business Strategies
          8.1.5 Recent Developments
    8.2 B. Braun Melsungen AG
          8.2.1 Company Overview
          8.2.2 Financial Overview
          8.2.3 Product Portfolio
          8.2.4 Business Strategies
    8.3 Becton, Dickinson & Company
          8.3.1 Company Overview
          8.3.2 Financial Overview
          8.3.3 Product Portfolio
          8.3.4 Business Strategies
          8.3.5 Recent Developments
    8.4 CareFusion Corporation
          8.4.1 Company Overview
          8.4.2 Financial Overview
          8.4.3 Product Portfolio
          8.4.4 Business Strategies
          8.4.5 Recent Developments
    8.5 Covidien Plc
          8.5.1 Company overview
          8.5.2 Financial overview
          8.5.3 Product portfolio
          8.5.4 Strategic overview
          8.5.5 Recent developments
    8.6 Fresenius Medical Care AG & Co. KGaA
          8.6.1 Company Overview
          8.6.2 Financial Overview
          8.6.3 Product Portfolio
          8.6.4 Strategic Overview
          8.6.5 Recent Developments
    8.7 Hospira, Inc.
          8.7.1 Company Overview
          8.7.2 Financial Overview
          8.7.3 Product Portfolio
          8.7.4 Business Strategies
    8.8 Medtronic, Inc.
          8.8.1 Company overview
          8.8.2 Financial Overview
          8.8.3 Product Portfolio
          8.8.4 Business Strategies
          8.8.5 Recent Developments
    8.9 Smiths Medical
          8.9.1 Company Overview
          8.9.2 Financial Overview
          8.9.3 Product Portfolio
          8.9.4 Business Strategies
          8.9.5 Recent Developments
    8.10 Teleflex Incorporated
          8.10.1 Company Overview
          8.10.2 Financial Overview
          8.10.3 Product Portfolio
          8.10.4 Strategies
          8.10.5 Recent Developments
    List of Tables
     
    TABLE 1 Market Snapshot: Global Intravenous Access Devices Market
    TABLE 2 Impact Analysis of Market Drivers
    TABLE 3 Impact Analysis of Market Restraints
    TABLE 4 Global Intravenous Access Devices Market Revenue, by Product Type, 2011 – 2019 (USD Billion)
    TABLE 5 Global Intravenous CatheterMarket Revenue, by Type, 2011 – 2019 (USD Billion)
    TABLE 6 Global Central CatheterMarket Revenue, by Type, 2011 – 2019 (USD Billion)
    TABLE 7 Global Intravenous Infusion PumpsMarket Revenue, by Type, 2011 – 2019 (USD Billion)
    TABLE 8 Global Intravenous Access Devices Market Revenue, by Geography, 2011 – 2019 (USD Billion)
    TABLE 9 Europe Geriatric Population Statistics (Million), 1991-2011

    List of Figures

     

    FIG. 1 Intravenous Access Devices Market Segmentation

    FIG. 2 Global Intravenous Access Devices Market, by Product Type, 2012 (USD Billion)

    FIG. 3 Global Rate of Aging Population

    FIG. 4 Porter’s Five Force Analysis: Global Intravenous Access Devices Market

    FIG. 5 Market Attractiveness Analysis: Global Intravenous Access Devices Market, by Geography (2012)

    FIG. 6 Comparative Analysis: Global Intravenous Access Devices Market, By Product Type, 2012 & 2019 (Value %)

    FIG. 7 Global Intravenous Needles Market Revenue, 2011 – 2019 (USD Billion)

    FIG. 8 Global Midline Peripheral Catheter Market Revenue, 2011 – 2019 (USD Billion)

    FIG. 9 Global Peripherally Inserted Central Catheter Market Revenue, 2011 – 2019 (USD Billion)

    FIG. 10 Global Centrally Inserted Central Catheter Market Revenue, 2011 – 2019 (USD Billion)

    FIG. 11 Global Intravenous Insulin infusion Pumps Market Revenue, 2011 – 2019 (USD Billion)

    FIG. 12 Global Parenteral Infusion Pumps Market Revenue, 2011 – 2019 (USD Billion)

    FIG. 13 Global Patient Controlled Analgesia (PCA) Infusion Pumps Market Revenue, 2011 – 2019 (USD Billion)

    FIG. 14 Global Syringe Infusion Pumps Market Revenue, 2011 – 2019 (USD Billion)

    FIG. 15 Comparative Analysis: Global Intravenous Access Devices Market, By Geography, 2012 & 2019 (Value %)

    FIG. 16 North America Intravenous Access Devices Market Revenue, 2011 – 2019 (USD Billion)

    FIG. 17 Europe Intravenous Access Devices Market Revenue, 2011 – 2019 (USD Billion)

    FIG. 18 Asia-Pacific Intravenous Access Devices Market Revenue, 2011 – 2019 (USD Billion)

    FIG. 19 Rest of the World (RoW) Intravenous Access Devices Market Revenue, 2011 – 2019 (USD Billion)

    FIG. 20 Market Share by Key Players, 2012 (%)

    FIG. 21 Baxter International: Annual Revenues, 2010 – 2012 (USD Million)

    FIG. 22 B. Braun Melsungen AG: Annual Sales, 2010 – 2012 (USD Million)

    FIG. 23 Becton, Dickinson and Company: Annual Revenues, 2010 – 2012 (USD Million)

    FIG. 24 CareFusion Corporation: Annual Revenues, 2010 - 2012 (USD Million)

    FIG. 25 Covidien Plc: Annual Revenues, 2010 – 2012 (USD Million)

    FIG. 26 Fresenius Medical Care AG & Co. KGaA: Annual Revenues, 2010 – 2012 (USD Million)

    FIG. 27 Hospira, Inc., Annual Sales: 2010 – 2012 (USD Millions)

    FIG. 28 Medtronic, Inc.: Annual Sales, 2010 – 2012 (USD Million)

    FIG. 29 Smiths Medical: Annual Sales, 2010 – 2012 (USD Million)

    FIG. 30 Teleflex Incorporated: Annual Revenue, 2010 – 2012 (USD Million)

Copyright © Transparency Market Research, Inc. All Rights reserved